Effects of Rice Bran on Radiation-Induced Oral Mucositis in Patients With Head/Neck Cancer and Its Impact on the Quality of Life

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to find out if taking rice bran supplements can help reduce the painful mouth sores (oral mucositis) that often occur in patients with head and neck cancer who receive radiation therapy. The trial will include adult patients undergoing radiation treatment. Participants will be given rice bran supplements during their therapy to see if it can lessen these side effects and improve their overall quality of life.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Male or female patients of age 18 years old tor more

• Patients with squamous cell carcinomas without metastases of other non-head and non-neck tumors.

• Patients undergoing radiotherapy with an ECOG performance status of 0, 1, or 2

• Patients who will receive IMRT delivered as radical or adjuvant therapy with or without concurrent chemotherapy

• Ready to provide written informed consent

Locations
Other Locations
Egypt
German university in cairo
RECRUITING
Cairo
Contact Information
Primary
Christina Milad Lobos, Master
Krstina.Bqtr@pharm.aun.edu.eg
+20 1005279101
Time Frame
Start Date: 2023-01-15
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 80
Treatments
Experimental: Rice Bran Supplement Group
Participants in this group will receive rice bran supplements daily during their radiation therapy. The supplement is intended to reduce the severity of oral mucositis and improve quality of life.
No_intervention: Control Group (Standard Care)
Participants in this group will receive standard care during radiation therapy without rice bran supplementation. Their oral mucositis symptoms and quality of life will be monitored for comparison.
Sponsors
Leads: Christina Milad Lobos

This content was sourced from clinicaltrials.gov